These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9340472)

  • 21. A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.
    Hotta N
    J Diabetes Investig; 2019 Jul; 10(4):906-908. PubMed ID: 31152685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of lactate acidosis as a side effect of biguanide therapy].
    Förster H
    Fortschr Med; 1976 Dec; 94(35-36):2065-71. PubMed ID: 1010516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biguanide-induced lactic acidosis in Finland.
    Korhonen T; Idänpään-Heikkilä J; Aro A
    Eur J Clin Pharmacol; 1979 Jul; 15(6):407-10. PubMed ID: 499289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB; Peters AL
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metformin-associated lactic acidosis].
    Orban JC; Ghaddab A; Chatti O; Ichai C
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1046-52. PubMed ID: 17005358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
    Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
    Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic optimisation of oral hypoglycaemic therapy.
    Marchetti P; Giannarelli R; di Carlo A; Navalesi R
    Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metformin efficacious in poorly controlled diabetes mellitus type 2].
    Stades AM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1897-900. PubMed ID: 11045134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin: a new oral biguanide.
    Campbell RK; White JR; Saulie BA
    Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Still sour about lactic acidosis years later: role of metformin in heart failure.
    Kuan W; Beavers CJ; Guglin ME
    Heart Fail Rev; 2018 May; 23(3):347-353. PubMed ID: 28868582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)].
    Deppermann D; Heidland A; Ritz E; Hörl W
    Klin Wochenschr; 1978 Sep; 56(17):843-53. PubMed ID: 713413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].
    Berger W; Mehnert-Aner S; Mülly K; Heierli C; Ritz R
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1830-4. PubMed ID: 1013709
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM; Iltz JL; Thams J; Campbell RK
    Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.